Product Program year 2022 Source: CMS Open Payments

Elekta Medical Linear Accelerator

Device Linac Solutions (Linac)

PDI 05060191071574

Open in the dashboard

General payments

$7,847,922

391 payments

Research payments

$0

0 payments

Through program year 2022, $7,847,922 in general payments and $0 in research payments were reported against Elekta Medical Linear Accelerator (Linac Solutions (Linac)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2022 General $134,023 211
2021 General $7,713,899 180

Breakdown

Who paid General payments · program years 2021–2022
  1. Elekta Limited $7,613,974 3 payments
  2. Elekta, Inc. $132,590 374 payments
  3. Nucletron Operations B.V. $80,373 5 payments
  4. Nucletron B.V. $20,063 4 payments
  5. Elekta Instrument AB $838 3 payments
  6. Elekta Medical S.A. de C.V. $43 1 payment
  7. Elekta LTD $41 1 payment
Top recipients General payments · program year 2022
  1. Vivek Mehta Radiation Oncology · Seattle, WA $38,338 29% · 7 payments
  2. Stanford Health Care Teaching hospital · CA $15,000 11% · 1 payment
  3. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $10,000 7% · 1 payment
  4. Rupesh Kotecha Radiation Oncology · Miami, FL $9,866 7% · 5 payments
  5. Michael Yunes Springfield, MA $7,759 6% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Radiation Oncology Radiology $77,997 97% · 118 practitioners
  2. Nurse Practitioner $903 1% · 1 practitioner
  3. Neurological Surgery $324 <1% · 3 practitioners
  4. Internal Medicine $174 <1% · 1 practitioner
  5. Anesthesiology $174 <1% · 1 practitioner

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Washington $38,838 29% · 5 recipients
  2. California $22,849 17% · 7 recipients
  3. Florida $18,549 14% · 16 recipients
  4. Michigan $15,819 12% · 10 recipients
  5. Massachusetts $7,811 6% · 4 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

391 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record